Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin by Ömercan Topaloğlu, Bahri Evren, İbrahim Şahin

Subjects: Get full text

Comparison of effects of Empagliflozin and Linagliptin on renal function and glycaemic control: a double-blind, randomized clinical trial by Mohammad Amin Mohammad zadeh Gharabaghi, Mohammad Reza Rezvanfar, Nasser Saeedi, Faezeh Aghajani, Mohammad Alirezaei, Pourya Yarahmadi, Amin Nakhostin-Ansari

Subjects: Get full text

Green quantitative methods for linagliptin and empagliflozin in dosage forms by Fraihat Safwan M.

Subjects: Get full text

Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post‐marketing surveillance study in Japan by Soulmaz Fazeli Farsani, Atsushi Taniguchi, Rie Ikeda, Kimberly G Brodovicz, Dorothee B Bartels

Subjects: Get full text

Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis by Juthi Adhikari, Taro Hirai, Emi Kawakita, Kunimitsu Iwai, Daisuke Koya, Keizo Kanasaki

Subjects: “…Linagliptin…”
Get full text

Peculiarities of the antiapoptotic Bcl-2 protein expression in liver in a model of obesity and type 2 diabetes and with linaglyptin correction by M. A. Cherepanova

Subjects: Get full text

Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus by Editorial team Diabetes Mellitus

Subjects: Get full text

HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular... by Eman A. Bahgat, Hisham Hashem, Hanaa Saleh, Ebraam B. Kamel, Maya S. Eissa

Subjects: Get full text

Neuroprotective Impact of Linagliptin against Cadmium-Induced Cognitive Impairment and Neuropathological Aberrations: Targeting SIRT1/Nrf2 Axis, Apoptosis, and Autophagy by Hany H. Arab, Ahmed H. Eid, Shuruq E. Alsufyani, Ahmed M. Ashour, Azza A. K. El-Sheikh, Hany W. Darwish, Gehan S. Georgy

Subjects: “…linagliptin…”
Get full text

A careful evaluation of the therapeutic choice is necessary in every phase of diabetes progression by Maria Elena Malighetti

Subjects: Get full text

Synthesis and Characterization of Process-Related Impurities of Antidiabetic Drug Linagliptin by Yiwen Huang, Xiaoqing He, Taizhi Wu, Fuli Zhang

Subjects: “…linagliptin…”
Get full text

Eighty-year-old diabetic patient with chronic stage IV renal insufficiency according to NKF by Carlo Percudani

Subjects: Get full text

Renal insufficiency and linagliptin therapy: a case report by Anna Corsi, Roberto Trevisan

Subjects: Get full text

Journey from EMPA-REG to CARMELINA to EMPEROR-Preserved: Empagliflozin/linagliptin in heart failure and diabetes by Sharvil S Gadve, Sneha Chavanda, Yashpal V Gogate, Vinayak Harale, Arundhati Dasgupta, Milind Patwardhan

Subjects: Get full text

A Comparison of Renal Effects between Empagliflozin and Linagliptin in Diabetic Patients with Chronic Kidney Disease: A Randomized Clinical Trial by Reza Zeinabadi Noghabi, Rojin Rouintan, Tahereh Sabaghian, Shayesteh Khalili

Subjects: Get full text

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans by Jin-Woo Park, Jong-Min Kim, Ji Hyeon Noh, Kyoung-Ah Kim, Hyewon Chung, EunJi Kim, Minja Kang, Ji-Young Park

Subjects: Get full text

New prospects in the treatment of diabetes mellitus by Minara Shamkhalovna Shamkhalova, Natalya Petrovna Trubitsyna, Marina Vladimirovna Shestakova

Subjects: Get full text

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers by Kang WY, Lee HW, Gwon MR, Cho S, Shim WS, Lee KT, Yang DH, Seong SJ, Yoon YR

Subjects: Get full text

Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with E... by Melanie Reijrink, Stefanie A. De Boer, Anniek M. Van Roon, Riemer H. J. A. Slart, Bernadette O. Fernandez, Martin Feelisch, Hiddo J. L. Heerspink, Harry Van Goor, Jan-Luuk Hillebrands, Douwe J. Mulder

Subjects: Get full text

A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world setting by Debmalya Sanyal, Soumava Gupta, Pratik Das

Subjects: “…Linagliptin…”
Get full text